Psychometric evaluation of the Moroccan version of the Bath Ankylosing Spondylitis Functional Index (BASFI) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) for use in patients with ankylosing spondylitis
Tóm tắt
The objectives of this study are to translate, adapt in the Moroccan cultural context, and validate in patients with ankylosing spondylitis (AS) the Bath Ankylosing Spondylitis Functional Index (BASFI) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI). The cross-cultural adaptation of the BASFI and BASDAI was obtained in accordance with the guidelines for translation of the health status measures. Eighty-five patients with AS were included in the study. The test–retest reliability and the internal consistency were analyzed, and both questionnaires were assessed for external construct validity. Structural validity was analyzed with correlation matrix. Twenty-four-hour test–retest reliability was good: BASFI intraclass correlation coefficient (ICC) = 0.96 (confidence interval (CI) at 95%, 0.93–0.97), BASDAI ICC = 0.93 (CI at 95%, 0.90–0.95). Cronbach’s alpha was 0.90 for the BASFI and 0.86 for BASDAI. The construct validity of the instruments was evaluated. The BASFI showed a strong validity when correlating its results with Schober’s test (r = −0.56), occipital wall distance (r = 0.46), chest expansion (r = −0.46), BASDAI (r = 0.54), Bath Ankylosing Spondylitis Metrology Index (r = 0.70), Bath Ankylosing Spondylitis Global Score (BAS-G; r = 0.58), Bath Ankylosing Spondylitis Radiology Index (r = 0.61), and the radiological changes in sacroiliac joints (r = 0.54). A good correlation was observed between the BASDAI and the spinal pain (r = 0.53), the number of nocturnal awakenings (r = 0.57), the morning stiffness (r = 0.65), the enthesic index (r = 0.47), the BAS-G (r = 0.53), the BASFI (r = 0.54), and the erythrocyte sedimentation rate (r = 0.41; for all p < 0.001). The correlation matrix showed an intermediate correlation between items. The Moroccan version of the BASFI and the BASDAI showed adequate reliability and validity. These instruments can be used in the clinical evaluation of Moroccan and Arabic-speaking patients with AS.
Tài liệu tham khảo
van der Heijde D, Calin A, Dougados M, Khan MA, van der Linden S, Bellamy N (1999) Selection of instruments in the core set for DC-art, SMARD, physical therapy, and clinical record keeping in ankylosing spondylitis. Progress report of the ASAS working group. Assessments in Ankylosing Spondylitis. J Rheumatol 26(4):951–954
Calin A, Garett S, Tenkinson T, Kenedy LG, Whelack H (1994) A new approach to defining functional ability in AS: the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 2:2281–2285
Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21(12):2286–2291
Jones SD, Steiner A, Garrett SL, Calin A (1996) The Bath Ankylosing Spondylitis Patient Global Score (BAS-G). Br J Rheumatol 35:66–71
Jenkinson TR, Mallorie PA, Whitelock HC, Kennedy LG, Calin A (1994) Defining spinal mobility in ankylosing spondylitis. The Bath AS Metrology Index(AS). J Rheumatol 21:1694–1698
MacKay K, Mack C, Brophy S, Calin A (1998) The Bath Ankylosing Spondylitis Radiology Index (BASRI): a new, validated approach to disease assessment. Arthritis Rheum 41:2263–2270
Guillemin F, Bombardier C, Beaton D (1993) Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidem 46:1417–1432
Guillemin F (1995) Cross cultural adaptation and validation of health status measures. Scand J Rheumatol 24:61–63
Pouchot J, Larbre JP, Lemelle I, Guillemin F, Prieur AM (2002) Validation of the French version of the Childhood Health Assessment Questionnaire (CHAQ) in juvenile idiopathic arthritis. Jt Bone Spine 69:468–481
Faucher M, Poiraudeau S, Lefevre-Colau MM, Rannou F, Fermanian J, Revel M (2003) Assessment of the test–retest reliability and construct validity of a modified Lequesne index in knee osteoarthritis. Joint Bone Spine 70:521–525
Schwartz D. Méthodes statistiques à l’usage des médecins et des biologistes. Ed Flammarion, 4ème Edition. Collection «statistique en biologie et en médecine», 1, Paris 1995: 20–42
El Miedany YM, El Gafary M, Ahmed I (2003) Cross-cultural adaptation and validation of an arabic health assessment questionnaire for use in rheumatoid arthritis patients. Joint Bone Spine 70:195–202
Claudepierre P, Sibilia J, Goupille FRM, Wendling D, Chevalier X (1994) Evaluation of a french version of the Bath Ankylosing Spondylitis Functional Index in patients with spondylarhtropathy. J Rheumatol 21:2281–2285
Cronstedt H, Waldner A, Stenstrom CH (1999) The Swedish version of the Bath Ankylosing Spondylitis Functional Index. Reliability and validity. Scand J Rheumtol 28:1111–1119
Ruof J, Sangha O, Stucki G (1999) Evaluation of German version of the Bath Ankylosing Spondylitis Functional Index (BASFI) and Dougados functional index (D-FI). Z Rheumtol 58:218–225
Hecnikkila S, Viitanen JV, Kautianen H et al (2000) Evaluation of the Finnish versions of the functional indices: BASFI and DFI in spondylartropathy. Clin Rheumtol 19:464–469
Cariel MH, Londono JD, Gutierrez E, Pacheco-Tena C et al (2003) Translation, cross-cultural adaptation and validation of the Bath Ankylosing Spondylitis Functional Index (BASFI), the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and the Dougados functional index (DFI) in Spanish speaking population with spondylartropathy. Clin Exp Rheumatol 21:451–458
Karatepe AG, AkkocY AS, Akkoc N (2005) The Turkish versions of the Bath Ankylosing Spondylitis and Dougados Functional Indices: reliability and validity. Rheumatol Int 25:612–618
Udrea G, Ciobanu C, Mihai C, Stoica V, Suteanu S, van der Heijde D, van der Linden S (2004) Evaluation of a Romanian version of the Bath Ankylosing Spondylitis Functional Index (BASFI) in patients with AS. Rom J Intern Med 42:199–209
Claudepierre P, Sibilia J, Goupille P et al (1997) Evaluation of a French version of the Bath Ankylosing Spondylitis Disease Activity Index in patients with spondylarhtropathiy. J Rheumatol 24:1954–1958
Cronstedt H, Waldner A (1999) Stenstrom CH The Swedish version of the Bath Ankylosing Spondylitis Disease Activity Index. Reliability and validity. Scand J Rheumtol 111:10–16
Brandt J, Westhof G, Rudwaleit M, Listing J, Zink A, Braun J, Sieper J (2003) Adaptation and validation of the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) for use in Germany. Z Rheumtol 62:264–273
Karatepe AG, Akkoc Y, Akar S et al (2005) The Turkish version of the Bath Ankylosing Spondylitis Disease Activity Index: reliability and validity. Rheumatol Int 25:280–2844
El Miedany Y, Youssef S, Mehanna A et al (2008) Defining disease status in ankylosing spondylitis: validation and cross-cultural adaptation of the Arabic Bath Ankylosing Spondylitis Functional Index (BASFI), the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), and the Bath Ankylosing Spondylitis Global score (BASG). Clin Rheumatol 27(5):605–612
Wei JC, Wong RH, Huang JH, Yu CT, Chou CT, Jan MS, Tsay GJ,1-- Chou MC, Lee HS (2007) Evaluation of internal consistency and re-test reliability of Bath ankylosing spondylitis indices in a large cohort of adult and juvenile spondylitis patients in Taiwan. Clin Rheumatol 26(10):1685–1691